Shandong Sinobioway Biomedicine Co., Ltd.
002581.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥2 | CN¥10 | CN¥10 | CN¥14 |
| - Cash | CN¥1 | CN¥0 | CN¥0 | CN¥0 |
| + Debt | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Enterprise Value | CN¥2 | CN¥9 | CN¥10 | CN¥14 |
| Revenue | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Growth | -16.1% | 20.4% | -11.3% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 79.8% | 78.3% | 78.7% | 78.7% |
| EBITDA | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| % Margin | -28.9% | -54.4% | -31% | -35.9% |
| Net Income | -CN¥0 | -CN¥0 | -CN¥0 | CN¥0 |
| % Margin | -38.1% | -77.4% | -4.1% | 67.3% |
| EPS Diluted | -0.6 | -0.5 | -0.022 | 0.41 |
| % Growth | -20% | -2,142.2% | -105.4% | – |
| Operating Cash Flow | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |